MedTrace Logo

Patent Foramen Ovale Closure in Older Patients

NCT04780022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2022-03-02

No results posted yet for this study

Summary

* Describe the baseline and procedural characteristics of older patients undergoing PFO closure due to cryptogenic embolism.
* Assess the long-term follow-up of this cohort, focusing on neurological events and their origin, major cardiac outcomes, as well as survival rates and death origin.
* Seek for predictors of neurological event recurrence after the procedure.

Conditions

Interventions

OTHER

Clinical events at last follow-up

Clinical events (stroke, transient ischemic attack, peripheral embolism, deep venous thrombosis, atrial fibrillation, myocardial infarction, bleeding episode, death) at last follow-up

Sponsors & Collaborators

  • Toronto General Hospital

    collaborator OTHER

  • Montreal Heart Institute

    collaborator OTHER

  • Ottawa Heart Institute

    collaborator UNKNOWN

  • St. Boniface Hospital

    collaborator OTHER

  • Hospital Clinico de Madrid

    collaborator UNKNOWN

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780022 on ClinicalTrials.gov